Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Standard

Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon. / Wested, Jakob.

2018. Abstract from Big Data i helsetjenesten , Oslo, Norway.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Harvard

Wested, J 2018, 'Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon', Big Data i helsetjenesten , Oslo, Norway, 06/06/2018 - 07/06/2018.

APA

Wested, J. (2018). Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon. Abstract from Big Data i helsetjenesten , Oslo, Norway.

Vancouver

Wested J. Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon. 2018. Abstract from Big Data i helsetjenesten , Oslo, Norway.

Author

Wested, Jakob. / Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon. Abstract from Big Data i helsetjenesten , Oslo, Norway.

Bibtex

@conference{bf4c6ae30c604178a059c438858690f8,
title = "{\AA} kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon",
abstract = "{"}Transparency policies and the increased technological ability to gather and process large amounts ofdata has created new possibilities and innovation dynamics to be seized and new legal and ethicalissues to be addressed in the biomedical area, where particularly overlapping legal claims are a centralissue. Patent claims, intellectual property rights and sui generis rights for data collections, trade secrets,regulatory data protection and the protection of personal data forms a complex legal frameworkapplying to the data supposed to fuel big data driven biomedical advances. Two of the central issues inthis landscape of rights and regulation are the problem of data aggregation and of data transparency.This presentation will focus on the role of Clinical research 2.0 in driving the development ofpersonalized medicine as well as Orphan drugs and the legal issues arising in this context related todata protection (GDPR) as well as IPR.{"}",
author = "Jakob Wested",
year = "2018",
month = jun,
day = "6",
language = "Dansk",
note = "null ; Conference date: 06-06-2018 Through 07-06-2018",
url = "https://www.jus.uio.no/ior/forskning/prosjekter/bigmed-jus/arrangementer/konferanser/bigdata/",

}

RIS

TY - ABST

T1 - Å kontrollere muligheter, navigere minefelt og beskytte interesser i Big Data-drevet bioteknologisk og biomedisinsk innovasjon

AU - Wested, Jakob

PY - 2018/6/6

Y1 - 2018/6/6

N2 - "Transparency policies and the increased technological ability to gather and process large amounts ofdata has created new possibilities and innovation dynamics to be seized and new legal and ethicalissues to be addressed in the biomedical area, where particularly overlapping legal claims are a centralissue. Patent claims, intellectual property rights and sui generis rights for data collections, trade secrets,regulatory data protection and the protection of personal data forms a complex legal frameworkapplying to the data supposed to fuel big data driven biomedical advances. Two of the central issues inthis landscape of rights and regulation are the problem of data aggregation and of data transparency.This presentation will focus on the role of Clinical research 2.0 in driving the development ofpersonalized medicine as well as Orphan drugs and the legal issues arising in this context related todata protection (GDPR) as well as IPR."

AB - "Transparency policies and the increased technological ability to gather and process large amounts ofdata has created new possibilities and innovation dynamics to be seized and new legal and ethicalissues to be addressed in the biomedical area, where particularly overlapping legal claims are a centralissue. Patent claims, intellectual property rights and sui generis rights for data collections, trade secrets,regulatory data protection and the protection of personal data forms a complex legal frameworkapplying to the data supposed to fuel big data driven biomedical advances. Two of the central issues inthis landscape of rights and regulation are the problem of data aggregation and of data transparency.This presentation will focus on the role of Clinical research 2.0 in driving the development ofpersonalized medicine as well as Orphan drugs and the legal issues arising in this context related todata protection (GDPR) as well as IPR."

M3 - Konferenceabstrakt til konference

Y2 - 6 June 2018 through 7 June 2018

ER -

ID: 210111285